论文信息 - Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody. - 字舞流文

Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.

N. Stambler | M. Saag | A. Marozsan | Paul J Maddon | W. Olson | B. Zingman | Y. Rotshteyn | J. Lalezari | J. Jacobson | M. Thompson | P. D'Ambrosio | S. Morris | P. Maddon